Enriqueta Vallejo‐Yagüe

Cardiovascular Safety Profile of Romosozumab: A Pharmacovigilance Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS)

Annika Vestergaard Kvist, Junaid Faruque, Enriqueta Vallejo‐Yagüe et al. · Journal of Clinical Medicine · 2021 · 77 citations · Full text

Thromboembolic Safety Reporting of Tofacitinib and Baricitinib: An Analysis of the WHO VigiBase

Enriqueta Vallejo‐Yagüe, Stefan Weiler, Raphael Micheroli et al. · Drug Safety · 2020 · 48 citations

Drug Safety, Thrombosis, Thromboembolic Safety Reporting +13

Sex and gender in infection and immunity: addressing the bottlenecks from basic science to public health and clinical applications

Chloé Pasin, Camila Rosat Consiglio, Jana S. Huisman et al. · Royal Society Open Science · 2023 · 20 citations · Full text

Health Care Disparity, Susceptible Host, Structural Bottleneck +22

The Unseen Hand: AI-Based Prescribing Decision Support Tools and the Evaluation of Drug Safety and Effectiveness

Harriet Dickinson, Dana Y. Teltsch, Jan Feifel et al. · Drug Safety · 2023 · 17 citations · Full text

Drug Safety, Substance Abuse, Unseen Hand +9

Minimal disease activity and remission in patients with psoriatic arthritis with elevated body mass index: an observational cohort study in the Swiss Clinical Quality Management cohort

Enriqueta Vallejo‐Yagüe, Theresa Burkard, Raphael Micheroli et al. · BMJ Open · 2022 · 15 citations · Full text